Categories: News

TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC.

TAMPA, FL / ACCESSWIRE / May 28, 2021 / TRxADE Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that the Company will be changing its name to TRxADE HEALTH, Inc., effective Tuesday, June 1, 2021, to reflect its new mission and strategic direction of the business.

The name change does not affect the rights of the Company’s stockholders, creditors, customers or suppliers. The Company’s common stock will continue to trade on the NASDAQ Capital Market under the current trading symbol “MEDS“. The Company’s current stockholders will not need to exchange their current stock certificates as the stock certificates reflecting the Company’s prior corporate name will continue to be valid. The name change is expected to be effective on The Nasdaq Capital Market on Tuesday, June 1, 2021.

“In 2020, we formed several companies focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. We believe the name “TRxADE HEALTH, INC.” will better describe the changed focus of the Company, to a health services IT company focused on digitalizing the retail pharmacy experience,” said Suren Ajjarapu, Chief Executive Officer of the Company.

About TRxADE Group, Inc.

TRxADE Group (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,100+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on TRxADE Group, please visit the Company’s IR website at investors.trxadegroup.com.

Investor Relations:

Lucas Zimmerman
Senior Vice President
MZ Group – MZ North America
(949) 259-4987
MEDS@mzgroup.us
www.mzgroup.us

SOURCE: Trxade Group, Inc.

View source version on accesswire.com:
https://www.accesswire.com/649589/TRxADE-Group-Inc-Announces-Name-Change-to-TRxADE-HEALTH-INC

Staff

Recent Posts

Innovaccer Launches AI Advisory Board to Drive Advances in Artificial Intelligence

Expanding its roster of technology leaders will enhance its ability to drive innovation and deliver…

2 hours ago

Virtual Second Opinions Save Over $8,700 Per Patient, New Analysis Finds

Third-party research confirms significant impact of specialty expertise on patients’ quality of life and costs…

2 hours ago

BioFuse Medical Technologies Appoints Dr. David Battleman as Chief Executive Officer

Proven healthcare executive and life sciences strategist joins to bring groundbreaking BioFuse Multi-Tissue Welder (MTW)…

2 hours ago

C2Dx Launches Next Generation Shaw Scalpel System – The Only Surgical Scalpel That Seals Vessels as it Cuts

Next Generation Shaw Scalpel Receives 510(k) Clearance, Ushering in a New Era of Surgical PrecisionKALAMAZOO,…

2 hours ago

Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific Region

RAHWAY, NJ / ACCESSWIRE / March 26, 2024 / The Merck Foundation, a private charitable…

2 hours ago

Winn Awards Help Physicians Solve Healthcare Disparities

NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Dr. Thomas Odeny grew up in…

2 hours ago